Neuropace shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9M | 187k | 10.31 |
| 2025-03-31 | $421k | 34k | 12.29 |
| 2024-12-31 | $473k | 42k | 11.19 |
| 2024-09-30 | $156k | 22k | 6.97 |
| 2024-06-30 | $181k | 24k | 7.56 |
| 2024-03-31 | $1.8M | 140k | 13.20 |